XBIT Earnings XBiotech Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–13 of 13
| FY 2025 | 2025-12-31 | -1.49 | 2026-03-13 | 10-K |
| FY 2024 | 2024-12-31 | -1.26 | 2025-03-18 | 10-K |
| FY 2023 | 2023-12-31 | -0.81 | 2024-03-15 | 10-K |
| FY 2022 | 2022-12-31 | -1.08 | 2023-03-15 | 10-K |
| FY 2021 | 2021-12-31 | -0.58 | 2022-03-15 | 10-K |
| FY 2020 | 2020-12-31 | -0.36 | 2021-03-16 | 10-K |
| Q4 2019 | 2019-12-31 | 14.82 | 2020-03-16 | 10-K |
| FY 2019 | 2019-12-31 | 14.44 | 2020-03-16 | 10-K |
| Q3 2019 | 2019-09-30 | -0.15 | — | — |
| Q2 2019 | 2019-06-30 | -0.16 | — | — |
| Q1 2019 | 2019-03-31 | -0.16 | — | — |
| FY 2018 | 2018-12-31 | -0.59 | — | — |
| FY 2017 | 2017-12-31 | -0.95 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.